Merck, Schering Win Initial OK For $42M Vytorin Deal

By Hilary Russ

Law360, New York (September 22, 2009, 12:37 PM ET) -- A federal judge has granted preliminary approval of a $41.5 million settlement in a multidistrict litigation asserting breach of contract and product liability claims against Schering-Plough Corp. and Merck & Co. Inc. over the marketing of cholesterol drug Vytorin.

Judge Dennis M. Cavanaugh of the U.S. District Court for the District of New Jersey on Thursday also approved the class for the purposes of the deal.

Both sides negotiated extensively for months and the settlement agreement was not the result of collusion, the order said....
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles